Amy Chalmers

Amy Chalmers is a Senior Scientist at Lonza since July 2025, bringing an extensive background in biochemistry and research. Prior to this role, Amy served as a Senior Research Associate at MiNK Therapeutics from January 2022 to July 2025, where expertise was developed in advanced scientific methodologies. Earlier experience includes a position as a Research Associate and a Genetic Technologist at Oncologica UK from July 2021 to January 2022. Amy Chalmers earned an MSci degree in Biochemistry from the University of Nottingham between 2017 and 2021.